In Addition it raises execution threat mainly because new builds have to recruit and coach scarce course of action engineers. If FDA expectations tighten for information integrity, Merck's scale and high quality units really should support secure continuity. A draw back scenario is slower ramp timing that forces higher dependence https://www.tjcy.com/industry-information/basics-of-pharmaceutical-raw-materials.html